Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by CJ Bottomley
Pnd116 - A Three Month Interim Analysis of Fingolimod Treatment Adherence for Relapsing Remitting Multiple Sclerosis in the Uk: The Patient Reported Outcomes With Fingolimod in Local Experience (Profile) Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study
Multiple Sclerosis International
Neurology
Fingolimod and CSF Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis
Neurology
Neurology
The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study
PLoS ONE
Multidisciplinary
A Randomized Study to Evaluate the Effect of Exercise on Fatigue in People With Relapsing–remitting Multiple Sclerosis Treated With Fingolimod
Multiple Sclerosis Journal - Experimental, Translational and Clinical
High Treatment Adherence, Satisfaction, Motivation, and Health-Related Quality of Life With Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis &Ndash; Results From a 24-Month, Multicenter, Open-Label Danish Study
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Expected Value of Partial Perfect Information for the Disability Progression Efficacy of Teriflunomide and Fingolimod in the Treatment of Relapsing-Remitting Multiple Sclerosis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cryptococcal Meningoencephalitis Treated With Fingolimod in a Patient With Multiple Sclerosis
Turkiye Klinikleri Journal of Case Reports
Erratum To: Fingolimod in the Treatment Algorithm of Relapsing Remitting Multiple Sclerosis: A Statement of the Central and East European (CEE) MS Expert Group
Wiener Medizinische Wochenschrift
Medicine
